Lone atrial fibrillation: Prognostic differences between paroxysmal and chronic forms after 10 years of follow-up

American Heart Journal

Volumn 137, Issue 4 I, 1999, Pages 686-691

  Scardi, S ^a   Mazzone, C ^a   Pandullo, C ^a   Goldstein, D ^a   Poletti, A ^a   Humar, F ^a  

^a MAGGIORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN EMBOLISM; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STROKE; SURVIVAL RATE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

EID: 0032911217     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70224-3     Document Type: Article

References (28)

1. Forfar JC, Miller HC, Toft AD. Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation. Am J Cardiol 1979;44:9-12.
2. Hinton RC, Kistler JP, Fallon JT, et al. Influence of etiology of atrial fibrillation on incidence of systemic embolism. Am J Cardiol 1977;40:509-13.
3. Kulbertus HE. Implications of lone atrial fibrillation/flutter in the context of cardiovascular fitness to fly. Eur Heart J 1992;13(suppl H):136-8.
4. Onundarson PT, Thorgeirsson G, Jonmundsson E, et al. Chronic atrial fibrillation: epidemiologic features and 14-year follow-up: a case control study. Eur Heart J 1987;8:521-7.
5. Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med 1987;317:669-74.
6. Furberg CD, Psaty BM, Manolio TA, et al. Prevalence of atrial fibrillation in elderly subjects (The Cardiovascular Health Study). Am J Cardiol 1994;74:236-41.
7. Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 1982;306:1018-22.
8. Gajewski J, Singer RB. Mortality in an insured population with atrial fibrillation. JAMA 1981;245:1540-4.
9. Godtfredsen J. Atrial fibrillation: etiology, course and prognosis: a follow-up study of 1212 cases. Copenhagen: Munksgaard; 1975.
10. Roy D, Marchand E, Gagnè P, et al. Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation. Am Heart J 1986;112:1039-43.
11. Davidson E, Rotemberg Z, Weimbeger I. Diagnosis and characteristics of lone atrial fibrillation. Chest 1989;95:1048-50.
12. Prystowsky EN, Benson DW, Fuster V, et al. AHA Medical Scientific Statement Special report: management of patients with atrial fibrillation. Circulation 1996;93:1262-77.
13. Stroke Prevention in Atrial Fibrillation Study Group Investigators. Preliminary report of the Stroke Prevention in Atrial fibrillation Study. N Engl J Med 1990;322:863-8.
14. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-11.
15. Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation (Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators). N Engl J Med 1992;327:1406-12.
16. Evans W, Swann P. Lone auricular fibrillation. Br Heart J 1954;16:189-94.
17. Brand FN, Abbott RD, Kannel WB, et al. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham study. JAMA 1985;254:3449-53.
18. Stanton MS, Miles WM, Zipes DP. Atrial fibrillation and flutter. In: Zipes DP, Jalife J, editors. Cardiac electrophysiology: From cell to bedside. Philadelphia: WB Saunders Company; 1990. p 735.
19. Fatkin D, Kuchar DL, Thorburn CW, et al. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications. J Am Coll Cardiol 1994;23:307-16.
20. Mügge A, Kuhn H, Nikutta P, et al. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. J Am Coll Cardiol 1994;23:599-607.
21. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57.
22. Manning WJ, Weintraub RM, Waksmonski CA, et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. Ann Intern Med 1995;123:817-22.
23. Bogousslavsky J, Adnet-Bonte C, Regli F, et al. Lone atrial fibrillation and stroke. Acta Neurol Scand 1990;82:143-6.
24. Flaker GC, Blackshear JL, McBride R, et al. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992;20:527-32.
25. Wellens HJ, Durrer R. Wolff-Parkinson-White syndrome and atrial fibrillation. Am J Cardiol 1974;34:777-82.
26. Close JB, Evans DW, Bailey SM. Persistent lone atrial fibrillation, its prognosis after clinical diagnosis. J Coll Gen Pract 1979;29:547-9.
27. Narayan SM, Cain ME, Smith JM. Atrial fibrillation. Lancet 1997;350:943-50.
28. Morocutti C, Amabile G, Fattapposta F, et al. Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. Stroke 1997;28:1015-21.